Cargando…
Detection of SARS-CoV-2 antibodies is insufficient for the diagnosis of active or cured COVID-19
We assessed the performance of Abbott's SARS-CoV-2 IgG assay and the Panbio(TM) COVID-19 IgG/IgM rapid test device for the diagnosis of either active or cured COVID-19. Three cohorts of patients were chosen. Cohort 1, patients (n = 65) who attended the emergency department on March 30, 2020 wit...
Autores principales: | Escribano, Pilar, Álvarez-Uría, Ana, Alonso, Roberto, Catalán, Pilar, Alcalá, Luis, Muñoz, Patricia, Guinea, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669901/ https://www.ncbi.nlm.nih.gov/pubmed/33199713 http://dx.doi.org/10.1038/s41598-020-76914-5 |
Ejemplares similares
-
Different performance of three point-of-care SARS-CoV-2 antigen detection devices in symptomatic patients and close asymptomatic contacts: a real-life study
por: Escribano, Pilar, et al.
Publicado: (2022) -
Sample pooling is efficient in PCR testing of SARS-CoV-2: a study in 7400 healthcare professionals
por: Estévez, Agustín, et al.
Publicado: (2021) -
High incidence of COVID-19 at nursing homes in Madrid, Spain, despite preventive measures
por: Escribano, Pilar, et al.
Publicado: (2022) -
Therapeutic Drug Monitoring of Antifungal Drugs: Another Tool to Improve Patient Outcome?
por: Vena, Antonio, et al.
Publicado: (2020) -
Outbreak of COVID-19 in a nursing home in Madrid
por: Bouza, Emilio, et al.
Publicado: (2020)